• Home
  • Triple Negative Breast Cancer

Triple Negative Breast Cancer

triplenegnews
Triple Negative Breast Cancer

The Novel Precision Cancer Medicine Datopotamab Deruxtecan Appears Promising in Triple Negative Breast Cancer

triplenegnews
Triple Negative Breast Cancer

Xeloda Reduces Risk of TNBC Recurrence

Image placeholder title
Triple Negative Breast Cancer

Trodelvy (sacituzumab govetecan) Treatment for Triple Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Keytruda & Other Checkpoint Inhibitor for Triple Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Trilaciclib for Triple-Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Update on Strategies to Improve Treatment for Triple Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Breast-Conserving Therapy May Outperform Mastectomy Alone for Women

Image placeholder title
Triple Negative Breast Cancer

Capivasertib in Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

To Remain Strong and Carry On: A Triple Neg Breast Cancer Survivors Story

Image placeholder title
Triple Negative Breast Cancer

Zejula - Keytruda Combination Therapy in TNBC

Image placeholder title
Triple Negative Breast Cancer

The CancerConnect Triple-Negative Breast Cancer Newsletter

Image placeholder title
Triple Negative Breast Cancer

Iniparib Promising in Metastatic Triple-negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Obesity Linked with Triple-Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Erbitux May Increase Response Rates in Metastatic Triple-Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Triple Negative Breast Cancer Linked with Higher Rate of Distant Metastases

Image placeholder title
Triple Negative Breast Cancer

Triple Negative Breast Cancer Foundation

Image placeholder title
Triple Negative Breast Cancer

New Breakthrough May Advance Triple Negative Breast Cancer Treatment

Image placeholder title
Triple Negative Breast Cancer

Biomarker May Help Improve Treatment of Triple-Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

No Benefit with Addition of Onartuzumab to Taxol® with or without Avastin®

Image placeholder title
Triple Negative Breast Cancer

Black Women Have Higher Rates of Triple-Negative Breast Cancer at All Ages

Image placeholder title
Triple Negative Breast Cancer

Radiation Improves Outcomes Among Elderly with Triple-Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Combination of Iniparib, Gemzar®, and Carboplatin for TNBC

Image placeholder title
Triple Negative Breast Cancer

Different Pattern of Recurrence for Triple-negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Abraxane® Combo Promising in Triple Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

FDA Seeks to Drug Development for Early-Stage, Triple-Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Combination of Afinitor and Chemotherapy Shows Promise in Metastatic Cancer

Image placeholder title
Triple Negative Breast Cancer

Potential New Target Identified in Triple-Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Gene Mutations In African American Women with Triple-Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Addition of Carboplatin Improves Outcomes in Triple Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Liquid Biopsy Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Erbitux plus Chemotherapy Promising in Triple-negative Breast Cancer

Image placeholder title
Triple Negative Breast Cancer

Trial Fails to Find Benefit of PARP Inhibitor for Metastatic TNBC

Image placeholder title
Triple Negative Breast Cancer

Breast-Conserving Therapy Comparable to Mastectomy for Women with Early-Stage

Image placeholder title
Triple Negative Breast Cancer

Iniparib Shows Promise Against Triple-Negative Breast Cancer